These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3107546

  • 1. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E, Velasco M, Silva H, Camejo G.
    Biomed Biochim Acta; 1987; 46(1):111-8. PubMed ID: 3107546
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 3. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
    Velasco M, Hurt E, Silva H, Urbina-Quintana A, Hernández-Pieretti O, Feldstein E, Camejo G.
    Am J Med; 1986 Feb 14; 80(2A):109-13. PubMed ID: 3080882
    [Abstract] [Full Text] [Related]

  • 4. Plasma lipid and lipoprotein changes in hypertensive patients treated with propranolol and prazosin.
    Gemma G, Montanari G, Suppa G, Paralovo A, Franceschini G, Mantero O, Sirtori CR.
    J Cardiovasc Pharmacol; 1982 Feb 14; 4 Suppl 2():S233-7. PubMed ID: 6177963
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
    Sasaki J, Koga S, Uzawa H, Arakawa K.
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug 14; 27(8):402-7. PubMed ID: 2676872
    [Abstract] [Full Text] [Related]

  • 6. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J, Saku K, Ideishi M, Arakawa K, Kato Y, Kuwano E, So T.
    Clin Ther; 1989 Aug 14; 11(2):219-24. PubMed ID: 2736568
    [Abstract] [Full Text] [Related]

  • 7. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Aug 14; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 8. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
    de Arcos F, Castelo-Branco C, Casals E, Sanllehy C, Cararach V.
    J Reprod Med; 1998 Feb 14; 43(2):144-8. PubMed ID: 9513877
    [Abstract] [Full Text] [Related]

  • 9. Effect of prazosin on blood lipids and on thyroid function in hypertensive patients.
    Velasco M, Silva H, Morillo J, Pellicer R, Urbina-Quintana A, Hernández-Pieretti O.
    J Cardiovasc Pharmacol; 1982 Feb 14; 4 Suppl 2():S225-7. PubMed ID: 6177961
    [Abstract] [Full Text] [Related]

  • 10. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P, Leduc G, Thibault G, Lepage J, Davignon J.
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec 14; 29(12):479-85. PubMed ID: 1839902
    [Abstract] [Full Text] [Related]

  • 11. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM, Creager MA, Gallagher SJ, Loscalzo J, Dzau VJ.
    Am J Med; 1989 Jan 23; 86(1B):8-13. PubMed ID: 2563311
    [Abstract] [Full Text] [Related]

  • 12. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL, Lenz ML, Taylor AA.
    J Hum Hypertens; 1990 Oct 23; 4 Suppl 3():23-33. PubMed ID: 1979819
    [Abstract] [Full Text] [Related]

  • 13. Randomised two way crossover comparison of the effects of six weeks propranolol and acebutolol therapy on plasma lipid profiles in patients with hypertension or ischaemic heart disease.
    Tyagi S, Bhargava M, Bhattacharya J, Khalilullah M.
    Indian Heart J; 1990 Oct 23; 42(2):117-9. PubMed ID: 2081608
    [Abstract] [Full Text] [Related]

  • 14. Serum lipid levels in hypertensive patients during captopril treatment.
    Nishide T, Shirai K, Shinomiya M, Ishikawa Y, Murano S, Morisaki N, Saito Y, Yoshida S, Sasaki N.
    Clin Ther; 1989 Oct 23; 11(6):820-7. PubMed ID: 2692824
    [Abstract] [Full Text] [Related]

  • 15. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Oct 23; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 16. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
    Rouffy J, Bakir R, Chanu B, Djian F, Goy-Loeper J, Henry Amar M, Renon D, Pappo M.
    Pathol Biol (Paris); 1986 Apr 23; 34(4):253-8. PubMed ID: 3529000
    [Abstract] [Full Text] [Related]

  • 17. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR, Franceschini G, Gianfranceschi G, Sirtori M, Montanari G, Tremoli E, Maderna P, Colli S, Zoppi F.
    J Lab Clin Med; 1987 Sep 23; 110(3):279-86. PubMed ID: 3475394
    [Abstract] [Full Text] [Related]

  • 18. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K.
    Int J Clin Pharmacol Ther; 1994 Dec 23; 32(12):660-4. PubMed ID: 7881705
    [Abstract] [Full Text] [Related]

  • 19. Beta blockers and their effects on lipoproteins, phospholipids, apoproteins A and B, in whole plasma and the different fractions.
    Bielmann P, Brun D, Gagné C, Morrjani S, Jéquier JC, Bertrand M, Lupien PJ.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun 23; 20(6):259-64. PubMed ID: 6125482
    [Abstract] [Full Text] [Related]

  • 20. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y, Shoji T, Emoto M, Kawasaki K, Konishi T, Tabata T, Inoue T, Morii H.
    Clin Nephrol; 1995 Apr 23; 43(4):268-77. PubMed ID: 7606882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.